Association of advanced therapies for intermediate- to high-risk pulmonary embolism with improved right ventricular function on outpatient follow-up among survivors - Top-Institutions - MDSpire

Association of advanced therapies for intermediate- to high-risk pulmonary embolism with improved right ventricular function on outpatient follow-up among survivors

  • By

  • Hammad Sheikh

  • Avinash Singh

  • Connor Smith

  • Howard Freeman

  • Abdul Rehman

  • Jeeyune Bahk

  • Sakul

  • Keshav Dixit

  • Alvin Yang

  • Maria Riasat

  • Robert Lookstein

  • Edgar Argulian

  • David J. Steiger

  • June 10, 2026

  • 0 min

Share

Top Institutions in Pulmonary

Brief introduction explaining scope and methodology.

  • #1

    Mount Sinai Health System
    Mount Sinai Health System

    New York, NY

    Key Differentiators

    • Cardiology

  • #2

    Heart Center of the University of Cologne
    Heart Center of the University of Cologne

    Cologne, Germany

    Key Differentiators

    • Cardiology

  • #3

    Pulmonary Embolism International Trial (PEITHO)-2
    Pulmonary Embolism International Trial (PEITHO)-2

    N/A, N/A

    Key Differentiators

    • Cardiology

Original Source(s)

Association of advanced therapies for intermediate- to high-risk pulmonary embolism with improved right ventricular function on outpatient follow-up among survivors

  • by Hammad Sheikh, Avinash Singh, Connor Smith, Howard Freeman, Abdul Rehman, Jeeyune Bahk, Sakul, Keshav Dixit, Alvin Yang, Maria Riasat, Robert Lookstein, Edgar Argulian, David J. Steiger

  • June 10, 2026

Related Content

Risk factors for prolonged respiratory support in late preterm infants: a LASSO-Cox regression analysis

Relapsing allergic bronchopulmonary aspergillosis as a trigger for Kounis syndrome: a case report

Remote Monitoring Approaches to Reduce Readmissions After Infection and Sepsis: A Randomized Clinical Trial